Navigation Links
ViroPharma to Present at the Natixis Bleichroeder Conference
Date:10/3/2007

EXTON, Pa., Oct. 3 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Michel de Rosen, president and chief executive officer of ViroPharma, will present at the Natixis Bleichroeder Conference at 10:30 A.M. ET on Monday, October 8, 2007. The conference is being held at the Carlton Hotel in New York.

ViroPharma's presentation will be webcast live for investors through http://www.viropharma.com and available through October 22, 2007.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company's website at http://www.viropharma.com.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. ViroPharma Announces Presentation of Additional HCV-796 Data at Meeting of The European Association for the Study of the Liver
2. The Past, Present and Future of HLA Typing
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)... Md., Dec. 1 Vanda Pharm...ion in The Lancet , one of the world,s leading me...novel circadian regulator, experimental compound t...am et al(1) is entitled "Melatonin agonist tasimel...time shift: two randomised controlled multicentre ...
(Date:12/1/2008)...IS, Dec. 1 Roche announced today t...ferences in perceived pain and,discomfort associa...ood,glucose monitoring systems and lancing device...cated that, overall, the ACCU-CHEK Aviva and ACCU-...s and the ACCU-CHEK Multiclix, ACCU-CHEK,Softclix...
(Date:12/1/2008)...inence is still the best policy , , ROCHES...w study from Mayo Clinic finds the use of the drug...lic hepatitis, an acute inflammation of the liver ...sults of the study are published in the December i...nal.org/ ). , , VIDEO ALERT: Additional au...
(Date:12/1/2008)...nce Call Scheduled for Tuesday, December 9 at 11:0... , , SOUTH SAN FRANCISCO, Calif., Dec. 1 ..., Inc. (Nasdaq: SNSS ), a biopharmaceutical comp...on of new oncology therapeutics, today announced n...loid leukemia (AML) will be presented during the 5...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3A bees future as queen or worker may rest with parasitic fly 4223 1A bees future as queen or worker may rest with parasitic fly 4223 2Nu Skin Enterprises and Toyo Bio Pharma Enter Agreement for Joint Product Research and Development 24435 1Nu Skin Enterprises and Toyo Bio Pharma Enter Agreement for Joint Product Research and Development 24435 2Healthcare Executives Well Rewarded for Their Work 24431 1Healthcare Executives Well Rewarded for Their Work 24431 2Hypnosis shown to reduce symptoms of dementia 24427 1
...cokinetics and Dose Proportionality of,Company,s O...tics,Journal -, LAVAL, QC, June 29, 2007 /PRNewswi...t it will present a poster discussing the dose,tit...t the 3rd,International Forum on Pain Medicine to ...a. , The poster compares two different titration s...
...2007: Chi-Med, the Hutchison Whampoa backed pharma...itive results for its Phase II,proof-of-concept st...litis, a form of inflammatory bowel disease. The ...tolerated and showed an,equivalent drop in clinica..., the current first-line standard of care in,mild-...
Other Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8
(Date:12/2/2008)...es that the SouthEast Alaska Regional Health Conso... Rhapsody™ Integration Engine to help the di...acy, laboratory and business programs communicate ...ity to statewide systems such as VacTrAK (the Stat...MIS and clinical documentation tool used by substa...
(Date:12/2/2008)...Population Services International (PSI) is launchi...ally reduce the number of African children dying e...ree artemisinin-based combination therapies (ACT) ...ildren suspected of having malaria. This quick-res...etermine if it reduces the number of African child...
(Date:12/1/2008)...Toy Puppies to the Obama Daughters , , WASH... been made of President-Elect Obama,s first promis...ughter,s asthma and allergies, and timing issues, .... So, in the meantime, the Asthma and Allergy Fou...mp; allergy friendly" toy puppies to the Obama chi...
(Date:12/1/2008)...tomography (CT) colonography, also known as virtua... diseases at oncecolorectal cancer and osteoporosi...0. Results of the study will be presented today at... North America (RSNA). , "With CT colonography, ... were able to identify patients with osteoporosis,...
Breaking Medicine News(10 mins):Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 2Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 3Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2Health News:CT colonography offers 1-stop screening for cancer and osteoporosis 2
...ain medications widely prescribed for rotator cuff...or cuff is composed of the muscles and tendons tha...it to the shoulder joint. The research involved 18...repair surgery. One-third of the rats were treated...
...antiretroviral therapy HAART, the cytomegalovirus ...ortunistic// infections that spread out of control...shorter time to death. Researchers assessed CMV s...HIV using a standard test. Investigators followed ...
...reened for cervical cancer, according to a new stu...routine // Pap smears are unnecessary for women wh...ancerous diseases. Since most of these women no lo...r cervical cancer. A survey done by researchers on...
...ption may be partly to blame for patients sufferin...ainly caused // by alcohol abuse and gall stones. ...nal pain, often accompanied by nausea and vomiting.... Researchers say pancreatitis has a poor prognosi...
Other Medicine News:
The Anterior Isola System is intended for use in correcting scoliotic, lordotic or kyphotic spinal deformities by establishing an axially stiff fixation bridge parallel to the long axis of the spine.
...Bowman Perfusion Monitor measures focal tissue per.... This precision instrument activates the minimall... connected by an umbilical cord to collect the dat... a host PC via serial port for processing, storage...
The Laserflo BPM2 is designed to give accurate and continuous cerebral blood flow data in neurosurgical intensive care, trauma, and operating room settings. The system is safe and easy to use, and pr
Oxyflo is a highly featured laser doppler system for continuous monitoring of microvascular blood perfusion from multiple tissue sites. This latest generation system incorporates developments in Digi
Medicine Products: